Eli Lilly and Company - Trending symbols
Trends
2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Net Working Capital | 896,300 | 3,905,100 | 4,801,400 | -2,384,800 | 2,416,600 | -1,407,800 | 1,008,800 | -2,575,000 | -1,566,200 | |
Net Income | 1,451,700 | 486,000 | 1,937,700 | -592,800 | 1,344,900 | 418,300 | 1,763,200 | -1,820,600 | -57,400 | |
Net Income from Continuing Operations | 1,451,700 | 486,000 | 1,937,700 | -592,800 | 1,344,900 | 418,300 | 1,763,200 | -1,820,600 | -57,400 | |
Net Income Applicable to Common Shares | 1,451,700 | 486,000 | 1,937,700 | -592,800 | 1,344,900 | 418,300 | 1,763,200 | -1,820,600 | -57,400 | |
Net Tangible Assets | -2,043,600 | -801,200 | -2,844,800 | 1,899,200 | -945,600 | 315,800 | -629,800 | 660,000 | 30,200 | |
Total Other Income Expense Net | -77,300 | -273,400 | -350,700 | 269,500 | -81,200 | -300 | -81,500 | 341,500 | 260,000 | |
Other Stockholders Equity | 3,767,500 | -174,900 | 3,592,600 | 89,700 | 3,682,300 | 83,000 | 3,765,300 | -10,673,600 | -6,908,300 | |
Interest Expense | 87,800 | -900 | 86,900 | -3,300 | 83,600 | -2,200 | 81,400 | -159,300 | -77,900 |
Comments
How you think about this?